Clinical trial
A Phase 2, Randomised, Controlled, Multicentre Two-Part Trial Assessing the Safety and Efficacy of TBAJ-587 as Part of a Combination Regimen in Newly Diagnosed, Drug-Sensitive, Sputum-Positive Pulmonary Tuberculosis
NCT07773610 is registered in ClinicalTrials.gov with TASK Applied Science as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomised, Controlled, Multicentre Two-Part Trial Assessing the Safety and Efficacy of TBAJ-587 as Part of a Combination Regimen in Newly Diagnosed, Drug-Sensitive, Sputum-Positive Pulmonary Tuberculosis
- Lead sponsor
- TASK Applied Science
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 25, 2026
- Completion date
- December 30, 2027
- Enrollment
- 135 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.